4//SEC Filing
HAYDEN BRIAN J 4
Accession 0001230295-07-000149
CIK 0000722104other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 21, 9:09 AM ET
Size
7.9 KB
Accession
0001230295-07-000149
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Award
Common Stock, $.01 par value per share
2007-02-15+23,860→ 23,860 total - Award
Option to Purchase Common Stock, $.01 par value
2007-02-15+24,255→ 24,255 totalExercise: $14.43From: 2008-02-15Exp: 2017-02-15→ Common Stock, $.01 par value per share (24,255 underlying)
Footnotes (2)
- [F1]The right to receive these shares is pursuant to a restricted stock grant and such shares issue and vest as to 33.3% on each of 2/15/08, 2/15/09 and 2/15/10, provided the grantee remains employed by the Company on these dates.
- [F2]These options will become exercisable as to 25% on each of 2/15/08, 2/15/09, 2/15/10 and 2/15/11, provided the optionee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001262224
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 21, 9:09 AM ET
- Size
- 7.9 KB